Tacrolimus Trough Concentrations are Not Impacted by Epstein–Barr Virus Serology and Viral Load in Pediatric Liver Transplant Recipients
This study suggests that the standard protocol of tacrolimus dosing does not seem to require adjustments due to changes in EBV serostatus or viral load.
Authors
- Daan J. Touw (ORCID: https://orcid.org/0000-0002-1429-4789)
- Arno R. Bourgonje (ORCID: https://orcid.org/0000-0001-5754-3821)
- Coretta van Leer‐Buter (ORCID: https://orcid.org/0000-0002-4072-7373)
- Hubert P. J. van der Doef (ORCID: https://orcid.org/0000-0001-7016-1860)
- René Scheenstra (ORCID: https://orcid.org/0000-0003-1686-2919)
- Jos G. W. Kosterink (ORCID: https://orcid.org/0000-0001-8358-765X)
- Paola Mian (ORCID: https://orcid.org/0000-0002-3551-1201)
- Amber M Te Lintelo
- Lisa F van Wier
Institutions
- University Medical Center Groningen (NL)
- University of Groningen (NL)
- Beatrix Kinderziekenhuis (NL)
- Icahn School of Medicine at Mount Sinai (US)
Publication Details
- Journal
- European Journal of Drug Metabolism and Pharmacokinetics
- Published
- 2025-06-17
- DOI
- https://doi.org/10.1007/s13318-025-00954-3
- Primary Topic
- Renal Transplantation Outcomes and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00